Radiation Medicine Patient Registry, Loma Linda University Medical Center
Launched by LOMA LINDA UNIVERSITY · May 4, 2015
Trial Information
Current as of August 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The patient registry will be posted to accomplish three objectives:
1. Perform retrospective research studies on diseases treated with proton therapy and conventional photon radiation.
2. Maintain regular and life-long contact with patients in order to obtain current identification, contact information, and self/parent-reported health status. This information is used to generate better understanding of treatment strategies and, in turn, increase benefits to patients.
3. Enable physicians to review of medical record information and so to identify subjects who may be eligible to participate ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of benign or malignant tumors or other conditions deemed treatable by proton or conventional photon radiotherapy
- • Willingness to sign an Informed Consent Document
- Exclusion Criteria:
- • There are no specific exclusion criteria, but patients who are unwilling to sign the ICD will not be included
About Loma Linda University
Loma Linda University is a prominent academic institution dedicated to advancing health and wellness through innovative research and education. As a sponsor of clinical trials, Loma Linda University leverages its extensive medical and scientific expertise to conduct rigorous studies aimed at improving patient outcomes and public health. With a commitment to ethical practices and patient safety, the university collaborates with a diverse network of healthcare professionals and researchers to explore novel therapeutic interventions and enhance clinical knowledge across various medical disciplines. Through its clinical trials, Loma Linda University seeks to contribute valuable insights to the medical community and foster advancements in healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Jerry D Slater, MD
Principal Investigator
Loma Linda University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials